Hans de Graaf

3.8k total citations
24 papers, 397 citations indexed

About

Hans de Graaf is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Hans de Graaf has authored 24 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 9 papers in Microbiology. Recurrent topics in Hans de Graaf's work include Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (8 papers) and Influenza Virus Research Studies (6 papers). Hans de Graaf is often cited by papers focused on Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (8 papers) and Influenza Virus Research Studies (6 papers). Hans de Graaf collaborates with scholars based in United Kingdom, Netherlands and United States. Hans de Graaf's co-authors include Saul N. Faust, Diane Gbesemete, Priya Sukhtankar, Robert C. Read, Sanjay Patel, Marc Tebruegge, Andrew Gorringe, Dimitri A. Diavatopoulos, Kent E. Kester and H.‐U. SCHUSTER and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Hans de Graaf

23 papers receiving 391 citations

Peers

Hans de Graaf

EPIDE

MICRO

IMMUN

Anna M. Acosta United States

Stephanie Jones South Africa

Luine Rosele Vidal Brazil

Goran Tešović Croatia

J Deák Hungary

Zsófia Mészner Hungary

Maria João Brito Portugal

Carla Talarico United States

Laurence Fissette Belgium

Jerry Labadie Netherlands

Anna M. Acosta United States

Hans de Graaf

306 ×1.4

EPIDE

132 ×0.7

204 ×2.2

MICRO

105 ×1.6

IMMUN

53 ×1.0

Citations per year, relative to Hans de Graaf Hans de Graaf (= 1×) peers Anna M. Acosta

Countries citing papers authored by Hans de Graaf

Since Specialization

Citations

This map shows the geographic impact of Hans de Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans de Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans de Graaf more than expected).

Fields of papers citing papers by Hans de Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans de Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans de Graaf. The network helps show where Hans de Graaf may publish in the future.

Co-authorship network of co-authors of Hans de Graaf

This figure shows the co-authorship network connecting the top 25 collaborators of Hans de Graaf. A scholar is included among the top collaborators of Hans de Graaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans de Graaf. Hans de Graaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graaf, Hans de, et al.. (2023). Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge. Journal of Clinical Investigation. 133(5). 8 indexed citations

Driessens, Corine, Lynne Mills, David Culliford, et al.. (2023). Psychological distress experienced by parents caring for an immunosuppressed child during the COVID-19 pandemic. Journal of Psychiatric Research. 161. 273–281.

Graaf, Hans de, Diane Gbesemete, & Robert C. Read. (2022). Controlled Human Infection with Bordetella pertussis. Current topics in microbiology and immunology. 445. 155–175. 1 indexed citations

Dale, Adam P., Anastasia A Theodosiou, Diane Gbesemete, et al.. (2022). Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial. The Lancet Microbe. 3(12). e931–e943. 7 indexed citations

Graaf, Hans de, Joshua Gillard, Pieter G. M. van Gageldonk, et al.. (2022). Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination. Nature Communications. 13(1). 7429–7429. 7 indexed citations

Driessens, Corine, Lynne Mills, David Culliford, et al.. (2022). Parental concern for clinically vulnerable child during first 18 months of the COVID pandemic. Pediatric Research. 94(1). 222–230. 5 indexed citations

Driessens, Corine, Alexander W. Tarr, William L. Irving, et al.. (2021). Immunocompromised children and young people are at no increased risk of severe COVID-19. Journal of Infection. 84(1). 31–39. 20 indexed citations

Zaric, Marija, Carolyn M. Nielsen, Gaurav Gupta, et al.. (2021). Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans. Frontiers in Immunology. 12. 732667–732667. 8 indexed citations

Driessens, Corine, Lynne Mills, Alice Leahy, et al.. (2021). COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open. 11(3). e044899–e044899. 11 indexed citations

10.

MacArthur, Iain, et al.. (2020). A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria. PLoS ONE. 15(4). e0232334–e0232334. 3 indexed citations

11.

Lwin, May, Christopher Holroyd, Dinny Wallis, et al.. (2020). Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?. Rheumatology Advances in Practice. 4(2). rkaa061–rkaa061. 1 indexed citations

12.

Gbesemete, Diane, Hans de Graaf, Andrew Vaughan, et al.. (2019). Protocol for a controlled human infection with genetically modifiedNeisseria lactamicaexpressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine. BMJ Open. 9(4). e026544–e026544. 6 indexed citations

13.

Coughlan, Lynda, Saranya Sridhar, Ruth Payne, et al.. (2018). Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults. EBioMedicine. 29. 146–154. 96 indexed citations

14.

Graaf, Hans de, Diane Gbesemete, Andrew Gorringe, et al.. (2018). 167. A Bordetella pertussis Human Challenge Model Induces Immunizing Colonization in the Absence of Symptoms. Open Forum Infectious Diseases. 5(suppl_1). S17–S17. 3 indexed citations

15.

Bruijning‐Verhagen, Patricia, et al.. (2017). Rotavirus disease course among immunocompromised patients; 5-year observations from a tertiary care medical centre. Journal of Infection. 75(5). 448–454. 5 indexed citations

16.

Graaf, Hans de, Diane Gbesemete, Andrew Gorringe, et al.. (2017). Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. BMJ Open. 7(10). e018594–e018594. 25 indexed citations

17.

Graaf, Hans de, Emanuela Pelosi, Andrea M. Cooper, et al.. (2016). Severe Enterovirus Infections in Hospitalized Children in the South of England. The Pediatric Infectious Disease Journal. 35(7). 723–727. 28 indexed citations

18.

Graaf, Hans de, et al.. (2015). Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. European Journal of Clinical Microbiology & Infectious Diseases. 34(7). 1281–1287. 26 indexed citations

19.

Graaf, Hans de & Saul N. Faust. (2015). Fluarix quadrivalent vaccine for influenza. Expert Review of Vaccines. 14(8). 1055–1063. 14 indexed citations

20.

Tebruegge, Marc, Chris Jones, Hans de Graaf, et al.. (2014). Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome. European Journal of Clinical Microbiology & Infectious Diseases. 34(3). 527–534. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact